Medications like semaglutide and liraglutide may help to reduce the risk of heart attacks, strokes, and other major adverse ...

Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or ...

Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...

Novo Nordisk will present data at the European Congress of Obesity (ECO) from a secondary, post hoc analysis of the SELECT ...

IT ONCE boasted over five million subscribers and saw one million of us stepping onto the scales every year. But Weight ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...

Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or obesity who have pre-existing cardiovascular disease but not diabetes, ...

Ozempic is a prescription drug used to deal with conditions related to high blood sugar levels and for diabetes management.

Mounjaro and Wegovy are two of the biggest names in the world of weight-loss drugs but it's been unclear which is more ...

While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...